Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Serious infections prevalent in RTX-treated patients with SLE
13 Feb 2024
A recent study has reported the prevalence of serious infection (SI) among patients with systemic lupus erythematosus (SLE) following treatment with rituximab (RTX).
Serious infections prevalent in RTX-treated patients with SLE
13 Feb 2024
Immunotherapy, TACE-based regimen may reshape HCC treatment landscape
13 Feb 2024
bởiAudrey Abella
In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.